ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04612	Antigen processing and presentation	5/25	77/7206	5.49290617667e-06
ko05164	Influenza A	5/25	167/7206	0.000229680587676
ko04650	Natural killer cell mediated cytotoxicity	4/25	97/7206	0.00031417766416
ko05152	Tuberculosis	5/25	187/7206	0.000388404698418
ko04668	TNF signaling pathway	4/25	120/7206	0.000705854414885
ko04380	Osteoclast differentiation	4/25	134/7206	0.00106782030916
ko04622	RIG-I-like receptor signaling pathway	3/25	62/7206	0.00121902282441
ko05161	Hepatitis B	4/25	173/7206	0.00273583144718
ko04210	Apoptosis	4/25	180/7206	0.0031584594861
ko05168	Herpes simplex infection	4/25	182/7206	0.00328699935782
ko05162	Measles	3/25	120/7206	0.00792915693509
ko04660	T cell receptor signaling pathway	3/25	124/7206	0.00867647474829
ko04142	Lysosome	3/25	151/7206	0.0147980879529
ko05321	Inflammatory bowel disease (IBD)	2/25	56/7206	0.0158706642705
ko04621	NOD-like receptor signaling pathway	3/25	157/7206	0.0164202086151
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/25	191/7206	0.0274613456804
ko01524	Platinum drug resistance	2/25	76/7206	0.0281586422046
ko04664	Fc epsilon RI signaling pathway	2/25	77/7206	0.0288487846642
ko04662	B cell receptor signaling pathway	2/25	88/7206	0.0368795821944
ko04658	Th1 and Th2 cell differentiation	2/25	96/7206	0.0432006711581
ko04064	NF-kappa B signaling pathway	2/25	96/7206	0.0432006711581